Nestin Expression Identifies Ependymoma Patients with Poor Outcome

Copy Number Gain of 1q25 Predicts Poor Progression-Free Survival for Pediatric Intracranial Ependymomas and Enables Patient Risk Stratification: A Prospective European Clinical Trial Cohort Analysis on Behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP)

(2012) J.-P. Kilday et al.   CLINICAL CANCER RESEARCH

A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat

(2011) Till Milde et al.   ACTA NEUROPATHOLOGICA

HTSanalyzeR: an R/Bioconductor package for integrated network analysis of high-throughput screens

(2011) X. Wang et al.   BIOINFORMATICS

Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma

(2011) Hendrik Witt et al.   CANCER CELL

The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse

(2011) Anna Merlos-Suárez et al.   Cell Stem Cell

Stem cell gene expression programs influence clinical outcome in human leukemia

(2011) Kolja Eppert et al.   NATURE MEDICINE

A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations

(2011) X. Yan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Using a Stem Cell-Based Signature to Guide Therapeutic Selection in Cancer

(2010) I. Shats et al.   CANCER RESEARCH

MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene Signature

(2010) N. Gaspar et al.   CANCER RESEARCH

Prognostic Significance of Nestin Expression in Resected Non-small Cell Lung Cancer

(2010) Shinichiro Ryuge et al.   CHEST

Molecular Staging of Intracranial Ependymoma in Children and Adults

(2010) Andrey Korshunov et al.   JOURNAL OF CLINICAL ONCOLOGY

Histone Deacetylase Inhibition Attenuates Cell Growth with Associated Telomerase Inhibition in High-Grade Childhood Brain Tumor Cells

(2010) R. Rahman et al.   MOLECULAR CANCER THERAPEUTICS

Cross-species genomics matches driver mutations and cell compartments to model ependymoma

(2010) Robert A. Johnson et al.   NATURE

Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion

(2010) D. Hussein et al.   NEURO-ONCOLOGY

Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas

(2010) F. Andreiuolo et al.   NEURO-ONCOLOGY

Testing the prediction error difference between 2 predictors

(2009) M. A. van de Wiel et al.   BIOSTATISTICS

Candidate Genes on Chromosome 9q33-34 Involved in the Progression of Childhood Ependymomas

(2009) Stéphanie Puget et al.   JOURNAL OF CLINICAL ONCOLOGY

Mbd3, a Component of NuRD/Mi-2 Complex, Helps Maintain Pluripotency of Mouse Embryonic Stem Cells by Repressing Trophectoderm Differentiation

(2009) Dongmei Zhu et al.   PLoS One

Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas

(2008) Camelia-Maria Monoranu et al.   CANCER GENETICS AND CYTOGENETICS

HDAC family: What are the cancer relevant targets?

(2008) Olaf Witt et al.   CANCER LETTERS

The role of the chromatin remodeler Mi-2  in hematopoietic stem cell self-renewal and multilineage differentiation

(2008) T. Yoshida et al.   GENES & DEVELOPMENT

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients

(2008) Mingyu Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Nestin expression in different tumours and its relevance to malignant grade

(2007) X H Yang et al.   JOURNAL OF CLINICAL PATHOLOGY